Ocstamp-flox Mouse

Ocstamp, short for osteoclast stimulatory transmembrane protein, is a key molecule in osteoclast multinucleation, a hallmark of osteoclast maturation. Along with DC-STAMP, it is considered a "master fusogen" in this process, enabling bone resorption by facilitating the reconstruction of the cytoskeleton to form the actin ring and ruffled border [1,4]. It is also involved in other cellular processes like epithelial-mesenchymal transition (EMT) and cellular senescence in alveolar type II epithelial cells, and may play a role in fibrotic processes related to silicosis [2,3,6].

In studies, overexpression of Ocstamp in MLE-12 cells (mouse alveolar type II epithelial cells) promoted EMT, endoplasmic reticulum (ER) stress, and cellular senescence. Knockdown of Ocstamp inhibited cellular senescence in these cells transfected with pcmv6-Ocstamp [3]. In silicosis, treatment with Ocstamp siRNA alleviated the progression of the disease in mice, suggesting its potential as a diagnostic and therapeutic target [6]. Also, molecules like resveratrol, luteolin, PKM2 activators, and glucan from baker's yeast were found to affect osteoclast differentiation and Ocstamp expression. Resveratrol inhibited doxorubicin-induced osteoclast differentiation and reduced Oc-stamp expression [5]. Luteolin alleviated cadmium-induced bone damage by reducing Oc-STAMP expression [7]. PKM2 activators inhibited osteoclast differentiation and affected osteoclast precursor cell fusion by downregulating Oc-STAMP [8]. Glucan from baker's yeast suppressed RANKL-induced osteoclastogenesis and downregulated Oc-stamp [9].

In conclusion, Ocstamp is crucial for osteoclast multinucleation and has implications in various disease-related cellular processes such as EMT, cellular senescence, and silicosis fibrosis. Studies using gene knockdown models, like siRNA-mediated Ocstamp inhibition in mice, have provided valuable insights into its role in these disease conditions, highlighting its potential as a biomarker and therapeutic target for silicosis and a key factor in understanding osteoclast-related bone diseases [3,6,8].